Therapeutic Vaccines

On the Blog

AVAC Report 2019: With 2020 targets sure to be missed, we ask Now What?

AVAC released Now What?, our 2019 annual report on the state of the HIV prevention field. Each year, the AVAC Report frames the most pressing advocacy issues facing the HIV response. At the threshold of 2020, it’s clear that global goals for HIV prevention will miss the mark by a long shot.

November 21, 2019

, HIV Vaccine, Combination Prevention, Male and Female Condoms, Microbicides, Multipurpose Prevention Technologies, PrEP, Therapeutic Vaccines, Treatment, Voluntary Medical Male Circumcision

AVAC

Follow the Money: HIV R&D Resource Tracking Reports 2018

The Resource Tracking for HIV Prevention R&D Working Group has launched its 15th annual report, HIV Prevention Research & Development Investments: Investing to end the epidemic, detailing overall 2018 investment and analysis of funding trends. And the Cure Resource Tracking Group has also released its annual report, Global Investment in HIV Cure Research and Development in 2018.

July 24, 2019

HIV Vaccine, Male and Female Condoms, Cure, Microbicides, PrEP, Therapeutic Vaccines, Treatment, Voluntary Medical Male Circumcision

AVAC

You are here

Therapeutic Vaccines

AVAC Report 2019: With 2020 targets sure to be missed, we ask Now What?

Follow the Money: HIV R&D Resource Tracking Reports 2018